FDA Inspection 1267912 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - March 14, 2025

Record Details

This FDA Inspection record concerns Wuhan Biocause Pharmaceutical Development Co., Ltd., with an inspection on March 14, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Wuhan Biocause Pharmaceutical Development Co., Ltd.
Inspection Date: March 14, 2025
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 5f5324f9-7060-4d3f-a7d8-749b3776af00